VANSEN PHARMA INC. Proceeds from Convertible Debt
VANSEN PHARMA INC. reported Proceeds from Convertible Debt of $2.75 million for the 101-month period ending 2013-09-30, per its 10-Q filed 2013-12-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2013-12-04
- 2013-09-30: Proceeds from Convertible Debt 9 month $2.75M; Proceeds from Convertible Debt 101 month $2.75M.
| Period end | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 101 month |
|---|---|---|
| 2013-09-30 | $2.75M 10-Q · filed 2013-12-04 | $2.75M 10-Q · filed 2013-12-04 |